Announcements Trials
Browse Landscape

Phase

Phase 3 10Phase 2 5Phase 1 3Phase 1/2 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Recurrence 4Leukemia 3Burkitt Lymphoma 3Neoplasms 2Lymphoma, T-Cell 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, T-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Lymphoid 1Leukemia, Biphenotypic, Acute 1

Interventions

Cyclophosphamide 48Filgrastim 21fludarabine phosphate 19Rituximab 19Etoposide 19Peripheral Blood Stem Cell Transplantation 17fludarabine 16Prednisone 16Vincristine 15Cytarabine 12Doxorubicin 11blinatumomab 8Methotrexate 8Dexamethasone 8Cyclosporine 8Bortezomib 8venetoclax 7Vorinostat 7Paclitaxel 7Melphalan 7Lenalidomide 7Calcium Dobesilate 7Biopsy 7Specimen Handling 6Radiotherapy 6Indium 6tanespimycin 5aldesleukin 5Tacrolimus 5Inotuzumab Ozogamicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Burkitt Lymphoma × pegaspargase × Clear all
NCT05157971 2026-05-28

Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia

City of Hope Medical Center

Phase 1 Active not recruiting
24 enrolled
Lymphoid

Burkitt Lymphoma

NCT03962465 2023-08-22

ALL-001

University of Virginia

Phase 1 Active not recruiting
36 enrolled
Lymphoid

Burkitt Lymphoma

NCT00866307 2021-04-27

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)

Children's Oncology Group

Phase 1 Completed
104 enrolled 9 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡